Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Ovarian Neoplasms 799Uterine Cervical Neoplasms 537Endometrial Neoplasms 459Breast Neoplasms 221Fallopian Tube Neoplasms 198Colorectal Neoplasms 179Carcinoma, Non-Small-Cell Lung 163Neoplasms 137Stomach Neoplasms 127Pancreatic Neoplasms 118Prostatic Neoplasms 107Neoplasm Metastasis 107Melanoma 107Lung Neoplasms 103Carcinoma, Ovarian Epithelial 92Triple Negative Breast Neoplasms 91Squamous Cell Carcinoma of Head and Neck 82Esophageal Neoplasms 77Head and Neck Neoplasms 75Carcinoma, Renal Cell 75Urinary Bladder Neoplasms 74Uterine Neoplasms 66Vulvar Neoplasms 64Colonic Neoplasms 59Peritoneal Neoplasms 58Carcinoma, Hepatocellular 58Uterine Cervical Dysplasia 57Sarcoma 52Carcinoma, Transitional Cell 48Papillomavirus Infections 47

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperplasia × Gynecologic × 1 year × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡